Stock KRSNAA KRSNAA DIAGNOSTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Krsnaa Diagnostics Limited Bombay S.E.

Equities

KRSNAA

INE08LI01020

Market Closed - Bombay S.E.
Other stock markets
 11:00:47 14/05/2024 BST 		5-day change 1st Jan Change
589.5 INR +0.68% Intraday chart for Krsnaa Diagnostics Limited -0.61% -16.43%
04-09 Krsnaa Diagnostics Forms New Wholly-Owned Subsidiary MT
02-13 Transcript : Krsnaa Diagnostics Limited, Q3 2024 Earnings Call, Feb 13, 2024

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's profit outlook over the next few years is a strong asset.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Analyst opinion has improved significantly over the past four months.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.74 times its estimated earnings per share for the ongoing year.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
KRSNAA DIAGNOSTICS LIMITED Stock Krsnaa Diagnostics Limited
-16.43% 226M -
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-13.90% 8.58B
B+
RADNET, INC. Stock RadNet, Inc.
+61.86% 4.12B
C+
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-3.34% 2.48B
B-
SYNLAB AG Stock SYNLAB AG
-9.46% 2.44B -
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-43.01% 2.29B
B-
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-2.84% 2B
C-
FLEURY S.A. Stock Fleury S.A.
-18.29% 1.53B
A-
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.24% 1.21B
C+
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+9.42% 1.12B
B+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. KRSNAA Stock
  4. KRSNAA Stock
  5. Ratings Krsnaa Diagnostics Limited